{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T15:11:15Z","timestamp":1773241875293,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T00:00:00Z","timestamp":1628294400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T00:00:00Z","timestamp":1628294400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Respiratory distress syndrome (RDS) is one of the leading causes of early neonatal morbidity and mortality in late preterm infants (LPIs) worldwide. This matched cohort study aimed to assess how the antenatal dexamethasone use affect the respiratory distress (RD) proportion in preterm newborns between 34 0\/7\u00a0weeks and 36 6\/7\u00a0weeks of gestation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a prospective cohort study on 78 women with singleton pregnancy who were in threatened preterm birth and had not received prior dexamethasone, who were admitted between 34 0\/7\u00a0weeks and 36 6\/7\u00a0weeks at Hue University of Medicine and Pharmacy Hospital from June 2018 to May 2020. The matched control group without dexamethasone use included 78 pregnant women diagnosed with threatened late preterm births who were at similar gestational ages and estimated fetal weights as the treatment group. The treatment group received 6\u00a0mg intramuscular dexamethasone every 12\u00a0h for a total of 4 doses or until delivery. Primary outcome was the rate of neonatal RD. Secondary neonatal outcomes included the need for respiratory support, neonatal intensive care unit (NICU) admission, hypoglycemia, necrotizing enterocolitis, intraventricular hemorrhage, and neonatal death. Statistical analyses were performed by using SPSS software, version 26.0.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The proportion of RD in LPI was significantly lower in the treatment group than in the matched control group (10.3% vs. 23.1%, respectively), adjusted Odds Ratio [aOR] 0.29; 95% confidence interval [CI] 0.10 \u2013 0.83 and p\u2009=\u20090.021. Neonatal hypoglycemia was more common in the dexamethasone group than in the matched group (25.6% vs. 12.8%, respectively; aOR, 2.59; 95% CI, 1.06 \u2013 6.33; p\u2009=\u20090.037). There were no significant between-groups differences in the incidence of respiratory support, NICU admission or length of hospital stay.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Administration of antenatal dexamethasone to women at risk for late preterm birth could help to lower the proportion of respiratory distress in late preterm infants.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12884-021-04019-6","type":"journal-article","created":{"date-parts":[[2021,8,7]],"date-time":"2021-08-07T07:02:51Z","timestamp":1628319771000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Antenatal dexamethasone use and respiratory distress in late preterm infants: results from first Vietnamese matched cohort study"],"prefix":"10.1186","volume":"21","author":[{"given":"Tran Tuan Hung","family":"Ho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quang Vinh","family":"Truong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thi Kim Anh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minh Tam","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vu Quoc Huy","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,8,7]]},"reference":[{"key":"4019_CR1","volume-title":"Born too soon: the global action report on preterm birth","author":"World Health Organization","year":"2012","unstructured":"World Health Organization. Born too soon: the global action report on preterm birth. Geneva: World Health Organization; 2012."},{"issue":"3","key":"4019_CR2","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1542\/peds.2006-0018","volume":"118","author":"TN Raju","year":"2006","unstructured":"Raju TN, Higgins RD, Stark AR, Leveno KJ. Optimizing care and outcome for late-preterm (near-term) infants: a summary of the workshop sponsored by the National Institute of Child Health and Human Development. Pediatrics. 2006;118(3):1207\u201314.","journal-title":"Pediatrics"},{"issue":"1","key":"4019_CR3","first-page":"1","volume":"64","author":"JA Martin","year":"2015","unstructured":"Martin JA, Hamilton BE, Osterman MJ, Curtin SC, Matthews TJ. Births: final data for 2013. Natl Vital Stat Rep. 2015;64(1):1\u201365.","journal-title":"Natl Vital Stat Rep"},{"issue":"1","key":"4019_CR4","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/j.1471-0528.1990.tb01711.x","volume":"97","author":"P Crowley","year":"1990","unstructured":"Crowley P, Chalmers I, Keirse MJNC. The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. BJOG. 1990;97(1):11\u201325.","journal-title":"BJOG"},{"issue":"4","key":"4019_CR5","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1542\/peds.50.4.515","volume":"50","author":"GC Liggins","year":"1972","unstructured":"Liggins GC, Howie RN. A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics. 1972;50(4):515\u201325.","journal-title":"Pediatrics"},{"issue":"2","key":"4019_CR6","first-page":"1","volume":"12","author":"National Institutes of Health","year":"1994","unstructured":"National Institutes of Health. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consens Statement. 1994;12(2):1\u201324.","journal-title":"NIH Consens Statement"},{"key":"4019_CR7","volume-title":"WHO recommendation on use of either dexamethasone or betamethasone as the antenatal corticosteroid of choice","author":"World Health Organization","year":"2015","unstructured":"World Health Organization. WHO recommendation on use of either dexamethasone or betamethasone as the antenatal corticosteroid of choice. Geneva: World Health Organization; 2015."},{"issue":"14","key":"4019_CR8","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1056\/NEJMoa1516783","volume":"374","author":"C Gyamfi-Bannerman","year":"2016","unstructured":"Gyamfi-Bannerman C, Thom EA, Blackwell SC, Tita AT, Reddy UM, Saade GR, et al. Antenatal Betamethasone for Women at Risk for Late Preterm Delivery. N Engl J Med. 2016;374(14):1311\u201320.","journal-title":"N Engl J Med"},{"issue":"2","key":"4019_CR9","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1097\/AOG.0000000000002237","volume":"130","author":"Committee Opinion No","year":"2017","unstructured":"Committee Opinion No. 713: Antenatal Corticosteroid Therapy for Fetal Maturation. Obstet Gynecol. 2017;130(2):e102\u20139.","journal-title":"Obstet Gynecol"},{"issue":"3","key":"4019_CR10","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1097\/AOG.0000000000003701","volume":"135","author":"Prelabor Rupture of Membranes","year":"2020","unstructured":"Prelabor Rupture of Membranes. ACOG Practice Bulletin Summary, Number 217. Obstetrics Gynecol. 2020;135(3):739\u201343.","journal-title":"Obstetrics Gynecol"},{"issue":"9957","key":"4019_CR11","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1016\/S0140-6736(14)60580-8","volume":"384","author":"JP Vogel","year":"2014","unstructured":"Vogel JP, Souza JP, G\u00fclmezoglu AM, Mori R, Lumbiganon P, Qureshi Z, et al. Use of antenatal corticosteroids and tocolytic drugs in preterm births in 29 countries: an analysis of the WHO Multicountry Survey on Maternal and Newborn Health. Lancet. 2014;384(9957):1869\u201377.","journal-title":"Lancet"},{"key":"4019_CR12","first-page":"25","volume":"23","author":"N Attawattanakul","year":"2015","unstructured":"Attawattanakul N, Tansupswatdikul P. Effects of Antenatal Dexamethasone on Respiratory Distress in Late Preterm Infant: a randomized controlled trial. Thai J Obstetrics Gynaecol. 2015;23:25\u201333.","journal-title":"Thai J Obstetrics Gynaecol"},{"key":"4019_CR13","volume-title":"Managing newborn problems: a guide for doctors, nurses and midwives","author":"World Health Organization","year":"2003","unstructured":"World Health Organization. Managing newborn problems: a guide for doctors, nurses and midwives. Geneva: World Health Organization; 2003."},{"key":"4019_CR14","doi-asserted-by":"crossref","unstructured":"Warren JB, Anderson J. Core Concepts: Respiratory Distress Syndrome. NeoReviews. 2009;10;e351\u2013e361.","DOI":"10.1542\/neo.10-7-e351"},{"issue":"6","key":"4019_CR15","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/S0957-5839(03)00080-0","volume":"13","author":"SJ Morris","year":"2003","unstructured":"Morris SJ. Radiology of the chest in neonates. Curr Paediatrics. 2003;13(6):460\u20138.","journal-title":"Curr Paediatrics"},{"key":"4019_CR16","doi-asserted-by":"crossref","unstructured":"Bastek JA, Langmuir H, Kondapalli LA, Par\u00e9 E, Adamczak JE, Srinivas SK. Antenatal corticosteroids for late-preterm infants: a decision-analytic and economic analysis. ISRN Obstet Gynecol. 2012;2012:491595.","DOI":"10.5402\/2012\/491595"},{"issue":"2","key":"4019_CR17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1055\/s-2007-1022471","volume":"25","author":"L Jain","year":"2008","unstructured":"Jain L. Respiratory morbidity in late-preterm infants: prevention is better than cure! Am J Perinatol. 2008;25(2):75\u20138.","journal-title":"Am J Perinatol"},{"key":"4019_CR18","doi-asserted-by":"crossref","unstructured":"Yinon Y, Haas J, Mazaki-Tovi S, Lapidot N, Mazkereth R, Hourvitz A, et al. Should patients with documented fetal lung immaturity after 34 weeks of gestation be treated with steroids? Am J Obstetrics Gynecol. 2012;207(3):222.e1\u2013.e4.","DOI":"10.1016\/j.ajog.2012.06.019"},{"issue":"9","key":"4019_CR19","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1038\/s41372-020-0589-1","volume":"40","author":"KR Uquillas","year":"2020","unstructured":"Uquillas KR, Lee RH, Sardesai S, Chen E, Ihenacho U, Cortessis VK, et al. Neonatal hypoglycemia after initiation of late preterm antenatal corticosteroids. J Perinatol. 2020;40(9):1339\u201348.","journal-title":"J Perinatol"},{"key":"4019_CR20","doi-asserted-by":"crossref","unstructured":"Porto AM, Coutinho IC, Correia JB, Amorim MM. Effectiveness of antenatal corticosteroids in reducing respiratory disorders in late preterm infants: randomised clinical trial. BMJ. 2011;342:d1696.","DOI":"10.1136\/bmj.d1696"},{"key":"4019_CR21","doi-asserted-by":"crossref","unstructured":"Badreldin N, Willert GG, Henricks AA, Peaceman A, Caldarelli LA, Yee LM. Implementation of an antenatal late-preterm corticosteroid protocol at a high-volume tertiary care center. Am J Obstetrics Gynecol MFM. 2020;2(1):100076.","DOI":"10.1016\/j.ajogmf.2019.100076"},{"issue":"5","key":"4019_CR22","doi-asserted-by":"publisher","first-page":"598","DOI":"10.3109\/14767058.2014.927428","volume":"28","author":"H Aly","year":"2015","unstructured":"Aly H, Hoffman H, El-Dib M, Said L, Mohamed M. Factor affecting length of stay in late preterm infants: an US national database study. J Matern Fetal Neonatal Med. 2015;28(5):598\u2013604.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"1","key":"4019_CR23","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3233\/NPM-16915086","volume":"9","author":"MK Ramadan","year":"2016","unstructured":"Ramadan MK, Hussein G, Saheb W, Rajab M, Mirza FG. Antenatal corticosteroids in the late preterm period: A prospective cohort study. J Neonatal Perinatal Med. 2016;9(1):15\u201322.","journal-title":"J Neonatal Perinatal Med"},{"issue":"2","key":"4019_CR24","first-page":"138","volume":"20","author":"P Sifianou","year":"2015","unstructured":"Sifianou P, Thanou V, Karga H. Metabolic and hormonal effects of antenatal betamethasone after 35 weeks of gestation. J Pediatr Pharmacol Ther. 2015;20(2):138\u201343.","journal-title":"J Pediatr Pharmacol Ther"},{"issue":"1","key":"4019_CR25","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.siny.2016.08.007","volume":"22","author":"DH Adamkin","year":"2017","unstructured":"Adamkin DH. Neonatal hypoglycemia. Semin Fetal Neonatal Med. 2017;22(1):36\u201341.","journal-title":"Semin Fetal Neonatal Med"},{"issue":"12","key":"4019_CR26","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1136\/archdischild-2019-317399","volume":"104","author":"T Salaets","year":"2019","unstructured":"Salaets T, Turner MA, Short M, Ward RM, Hokuto I, Ariagno RL, et al. Development of a neonatal adverse event severity scale through a Delphi consensus approach. Arch Dis Childhood. 2019;104(12):1167.","journal-title":"Arch Dis Childhood"},{"issue":"3","key":"4019_CR27","doi-asserted-by":"publisher","first-page":"F195","DOI":"10.1136\/archdischild-2012-303157","volume":"98","author":"PR Stutchfield","year":"2013","unstructured":"Stutchfield PR, Whitaker R, Gliddon AE, Hobson L, Kotecha S, Doull IJ. Behavioural, educational and respiratory outcomes of antenatal betamethasone for term caesarean section (ASTECS trial). Arch Dis Child Fetal Neonatal Ed. 2013;98(3):F195-200.","journal-title":"Arch Dis Child Fetal Neonatal Ed"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-04019-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-021-04019-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-021-04019-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T16:48:01Z","timestamp":1673023681000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-021-04019-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,7]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["4019"],"URL":"https:\/\/doi.org\/10.1186\/s12884-021-04019-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-146925\/v1","asserted-by":"object"}]},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,7]]},"assertion":[{"value":"11 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from Hue University of Medicine and Pharmacy\u2019s Ethics Committee for Biomedical Research, Approval No. H2018\/357.Written consent was obtained from all study participants before their enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"546"}}